兒童肥胖管理市場規模、佔有率和成長分析：按治療類型、生活方式和行為管理、藥物治療、最終用戶、年齡層、配銷通路和地區分類——2026-2033年行業預測

2024 年全球兒童肥胖症管理市場價值為 39 億美元，預計到 2025 年將成長至 42.5 億美元，到 2033 年將成長至 85.4 億美元，預測期（2026-2033 年）複合年成長率為 9.1%。

兒童肥胖症盛行率的上升，以及人們對相關健康風險認知的提高，正顯著推動兒童肥胖症管理市場的發展。數位化健康解決方案的普及、體重管理療法的廣泛應用以及政府的支持措施，都在提升肥胖症預防的有效性。糖尿病、心血管疾病和代謝紊亂發病率的上升，凸顯了製定綜合體重管理方案的必要性。數位化技術和個人化營養策略的應用，正在提高患者的參與度和治療效果。此外，肥胖症管理保險覆蓋範圍的擴大以及創新的學校健康促進舉措，也創造了新的市場機會。然而，高昂的治療費用、較低的依從性、社會歧視以及對藥物治療安全性的擔憂等挑戰，可能會阻礙市場成長。

全球兒童肥胖管理市場按治療類型、生活方式和行為管理、藥物治療、最終用戶、年齡層、分銷管道和地區進行細分。按治療類型分類，市場分為生活方式和行為管理、營養療法、藥物治療、減重手術和其他。依生活方式和行為管理分類，市場分為體育活動項目、行為諮詢、家庭參與的體重管理項目和其他。依藥物治療分類，市場分為GLP-1受體促效劑、脂肪酶抑制劑、抗肥胖藥物聯合治療及其他。按最終用戶分類，市場分為醫院、小兒科診所、肥胖中心、居家照護機構和其他。依年齡層別分類，市場分為「兒童（6-12歲）」、「青少年（13-18歲）」及其他。根據分銷管道，市場分為「醫院藥房」、「零售藥房」、「線上藥局」和其他管道。根據地區，市場分為「北美」、「歐洲」、「亞太」、「拉丁美洲」以及「中東和非洲」。

全球兒童肥胖症管理市場的成長要素

大眾對兒童肥胖長期影響的認知不斷加深，促使家長、教育機構和醫療保健專業人員更加關注預防和治療方案。這種意識的提高有望刺激對有針對性的管理項目和產品的需求，從而重振市場活力。隨著早期篩檢和消費者教育（包括不依賴藥物治療的健康生活方式選擇）的日益重視，包括政策制定者、保險公司和創新者在內的相關人員之間的合作將更加有效。這種合作環境有望在兒童肥胖管理領域創造新的機遇，並最終有助於開發更全面的解決方案來應對這一緊迫挑戰。

全球兒童肥胖症管理市場的限制因素

全球兒童肥胖症管理市場面臨的主要限制因素是各種肥胖症干預計畫的保險覆蓋不足。由於缺乏保險，患者往往需要自行承擔治療費用，導致體重管理舉措的參與率較低。保險費、自付部分以及必要的家用設備費用都需計入患者的自付費用，這使得家庭難以堅持長期治療。由於許多服務的費用超出保險覆蓋範圍，持續治療的高昂成本常常使患者放棄尋求有效的解決方案，阻礙了兒童肥胖症管理行業的成長。

兒童肥胖症管理市場的全球趨勢

全球兒童肥胖症管理市場正呈現向數位化療法融合的顯著趨勢。臨床醫生擴大利用先進的數位平台，包括智慧型手機應用程式、生物感測器技術和人工智慧驅動的指導，來最佳化肥胖青少年的治療。這種轉變增強了遠端監測和溝通，使患者能夠持續參與治療，並可在無需面對面就診的情況下快速調整治療方案。此外，與電子健康記錄系統的無縫整合，能夠即時追蹤患者的進度並快速調整治療方案。隨著這些技術的有效性和擴充性得到證實，它們在兒童肥胖症管理中的重要性預計將進一步提升，從而改變醫療專業人員應對這一日益嚴峻挑戰的方式。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球兒童肥胖症管理市場規模：依治療類型分類

• 生活方式/行為管理
• 營養療法
• 藥物治療
• 減重手術
• 其他

全球兒童肥胖管理市場規模：依生活型態和行為管理分類

• 體育活動計劃
• 行為諮詢
• 家庭參與式體重管理計劃
• 其他

全球兒童肥胖症管理市場規模：依藥物療法分類

• GLP-1受體促效劑
• 脂肪酶抑制劑
• 抗肥胖複方藥物
• 其他

全球兒童肥胖管理市場規模：依最終用戶分類

• 醫院
• 小兒科診所
• 肥胖治療中心
• 居家照護環境
• 其他

全球兒童肥胖症管理市場規模：依年齡層別分類

• 兒童（6-12歲）
• 青少年（13-18歲）
• 其他

全球兒童肥胖管理市場規模：依通路分類

• 醫院藥房
• 零售藥房
• 網路藥房
• 其他

全球兒童肥胖管理市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Novo Nordisk
• Eli Lilly and Company
• Pfizer
• Roche
• Rhythm Pharmaceuticals
• Currax Pharmaceuticals
• Vivus
• Amgen
• AstraZeneca
• Boehringer Ingelheim
• Takeda Pharmaceutical
• Abbott Laboratories
• Nestle Health Science
• WW International（WeightWatchers）
• Hims & Hers Health
• Teladoc Health
• Noom
• Omada Health
• Cigna Healthcare
• UnitedHealth Group

結論與建議

Global Pediatric Obesity Management Market size was valued at USD 3.9 Billion in 2024 and is poised to grow from USD 4.25 Billion in 2025 to USD 8.54 Billion by 2033, growing at a CAGR of 9.1% during the forecast period (2026-2033).

The rising prevalence of childhood obesity, coupled with heightened awareness of associated health risks, is significantly boosting the pediatric obesity management market. The integration of digital health solutions, access to weight management therapies, and supportive government initiatives are enhancing the effectiveness of obesity interventions. Growing incidences of diabetes, cardiovascular issues, and metabolic disorders emphasize the need for comprehensive weight management programs. The adoption of digital technologies and personalized nutrition strategies is improving patient engagement and treatment outcomes. Additionally, expanded insurance coverage for obesity management and innovative school-based wellness initiatives are creating new market opportunities. However, challenges such as high treatment costs, limited adherence, social stigma, and concerns over the safety of pharmacological treatments may hinder market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pediatric Obesity Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pediatric Obesity Management Market Segments Analysis

Global pediatric obesity management market is segmented by treatment type, lifestyle & behavioral management, pharmacological therapy, end user, age group, distribution channel, and region. Based on treatment type, the market is segmented into lifestyle & behavioral management, nutritional therapy, pharmacological therapy, bariatric surgery, and others. Based on lifestyle & behavioral management, the market is segmented into physical activity programs, behavioral counseling, family-based weight management programs, and others. Based on pharmacological therapy, the market is segmented into GLP-1 Receptor Agonists, Lipase Inhibitors, combination anti-obesity drugs, and others. Based on end user, the market is segmented into hospitals, pediatric clinics, specialty obesity centers, homecare settings, and others. Based on age group, the market is segmented into children (6-12 years), adolescents (13-18 years), and others. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Driver of the Global Pediatric Obesity Management Market

Rising public understanding of the long-term consequences of pediatric obesity is driving increased interest in both preventive and therapeutic solutions among parents, educational institutions, and healthcare professionals. This growing awareness is spurring a demand for targeted management programs and products, which will subsequently stimulate market activity. As the emphasis on early screening and consumer education regarding healthy lifestyle choices without relying on medication intensifies, stakeholders-including policymakers, insurers, and technology innovators-will collaborate more effectively. This collaborative environment is expected to foster new opportunities within the pediatric obesity management space, ultimately contributing to more comprehensive solutions for this pressing issue.

Restraints in the Global Pediatric Obesity Management Market

A significant limitation in the Global Pediatric Obesity Management market is the inadequate insurance coverage for various obesity intervention programs. This shortfall leads to low participation rates in weight management initiatives, as patients frequently bear the financial burden of treatment expenses themselves. With insurance premiums, copayments, and costs for necessary home equipment contributing to out-of-pocket expenses, families may find it challenging to commit to long-term treatment options. As many services exceed their covered limits, the high costs associated with ongoing therapies often deter patients from pursuing effective solutions, which is likely to hinder growth within the pediatric obesity management sector.

Market Trends of the Global Pediatric Obesity Management Market

The Global Pediatric Obesity Management market is experiencing a significant trend towards the integration of digital therapeutics. Clinicians are increasingly leveraging advanced digital platforms, including smartphone applications, biosensor technology, and artificial intelligence coaching, to optimize treatment for youth suffering from obesity. This shift allows for enhanced virtual monitoring and communication, enabling continuous patient engagement and swift intervention adjustments without the need for in-person visits. Furthermore, the seamless integration with electronic medical record systems facilitates real-time tracking of patient progress and the rapid adaptation of treatment plans. As these technologies prove effective and scalable, their prominence in pediatric obesity management is expected to expand, transforming how healthcare professionals address this growing concern.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Pediatric Obesity Management Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Lifestyle & Behavioral Management
• Nutritional Therapy
• Pharmacological Therapy
• Bariatric Surgery
• Others

Global Pediatric Obesity Management Market Size by Lifestyle & Behavioral Management & CAGR (2026-2033)

• Market Overview
• Physical Activity Programs
• Behavioral Counseling
• Family-Based Weight Management Programs
• Others

Global Pediatric Obesity Management Market Size by Pharmacological Therapy & CAGR (2026-2033)

• Market Overview
• GLP-1 Receptor Agonists
• Lipase Inhibitors
• Combination Anti-Obesity Drugs
• Others

Global Pediatric Obesity Management Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Pediatric Clinics
• Specialty Obesity Centers
• Homecare Settings
• Others

Global Pediatric Obesity Management Market Size by Age Group & CAGR (2026-2033)

• Market Overview
• Children (6-12 Years)
• Adolescents (13-18 Years)
• Others

Global Pediatric Obesity Management Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Global Pediatric Obesity Management Market Size & CAGR (2026-2033)

• North America (Treatment Type, Lifestyle & Behavioral Management, Pharmacological Therapy, End User, Age Group, Distribution Channel)
  • US
  • Canada
• Europe (Treatment Type, Lifestyle & Behavioral Management, Pharmacological Therapy, End User, Age Group, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Lifestyle & Behavioral Management, Pharmacological Therapy, End User, Age Group, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Lifestyle & Behavioral Management, Pharmacological Therapy, End User, Age Group, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Lifestyle & Behavioral Management, Pharmacological Therapy, End User, Age Group, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Novo Nordisk
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rhythm Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Currax Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vivus
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle Health Science
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WW International (WeightWatchers)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hims & Hers Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teladoc Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Noom
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omada Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cigna Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UnitedHealth Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations